Federal Register #337TA1508

ITC Investigation: Patent Infringement Allegations for Proteomics Systems and Supplies

This opportunity involves a U.S. International Trade Commission investigation into alleged patent infringement related to products for studying proteins. - Government Buyer: - U.S. International Trade Commission - Complainants: - Seer, Inc. - The Brigham and Women's Hospital, Inc. - Products/Services in Scope: - Automated workstations for proteomics - Associated software for proteomics - Assay kits for proteomics - Nanoparticles, reagents, and laboratory consumables - Notable Requirements: - Investigation concerns alleged violations of section 337 of the Tariff Act of 1930 - Focus on importation, sale for importation, and sale within the U.S. of the above products - Requests for limited exclusion order and cease and desist order - OEMs: - No specific OEMs or vendors named for accused products - Complainants are Seer, Inc. and The Brigham and Women's Hospital, Inc.

Description

A complaint was filed with the U.S. International Trade Commission alleging violations of section 337 based on the importation, sale for importation, and sale within the United States of certain systems, devices, software, compositions, chemicals, and laboratory supplies for studying proteins. The complaint alleges infringement of several U.S. patents and requests the Commission to institute an investigation and issue a limited exclusion order and a cease and desist order. The investigation will determine if there is a violation of section 337 and if an industry in the United States exists as required by law. The accused products include automated workstations for proteomics, associated software, assay kits, and components such as nanoparticles, reagents, and laboratory consumables.

View original listing